---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-033017"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:46:37.569980+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ImmuCell names Olivier te Boekhorst CEO; board expanded to nine directors

## Summary
- Olivier te Boekhorst started as President and CEO on Nov 1, 2025, succeeding Michael Brigham.
- Board expanded from 7 to 9 directors; te Boekhorst and CFO Timothy Fiori elected as directors.
- Michael Brigham remains board member and Special Advisor to CEO until January 2026.
- CFO Fiori also appointed Secretary and Treasurer.
- Company to host Q3 earnings conference call on Nov 14, 2025 at 9:00 AM ET.

## SEC filing metadata
- accession: 0001437749-25-033017
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01, 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/0001437749-25-033017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/iccc20251103_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-033017
- JSON: https://secwatch.observer/filing/0001437749-25-033017.json
- Plain text: https://secwatch.observer/filing/0001437749-25-033017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.